Sandra,
For me this would also fall under "claims" that an organisation would be making. As Ed said, if there is a perceived shift in a person's treatment because they are waiting for something better, instead of getting treatment now, imagine many regulators would take exception to that. Just like any claim, there needs to be substantiated evidence support any statements made, especially forward looking statements. Now try to convince the sales and marketing teams of not making certain statements haha.
------------------------------
Richard Vincins RAC
Vice President Global Regulatory Affairs
------------------------------
Original Message:
Sent: 07-Dec-2021 14:25
From: Ed Panek
Subject: "Forward looking statements" Disclaimer
I have heard FDA has issues with future statements that could impact current patient safety today. For example, "Coming soon, a pill that cures some disease." The FDA would be concerned people in susceptible patient populations would be harmed in waiting for this unapproved treatment in lieu of currently approved treatments.
------------------------------
Edward Panek
VP, QA/RA
Med Device
USN Veteran
Research into Neural Nets - https://www.twitch.tv/edosani
Original Message:
Sent: 07-Dec-2021 13:42
From: Sandra Veenstra
Subject: "Forward looking statements" Disclaimer
Hi All, been seeing a lot of "forward looking statements' disclaimers on websites/marketing material for medical devices. Is this an acceptable safe harbor to regulators for future oriented claims re: devices under development? Or do regulators (e.g. FDA) have a higher standard for potentially misleading claims?
------------------------------
Sandra Veenstra
Director - Quality Assurance and Regulatory Affair
Moncton NB
Canada
------------------------------